Cancer Terms

MET Tyrosine Kinase Inhibitor PF-02341066

Cancer Terms -> Drugs and Chemicals -> Pharmacologic Substance -> Enzyme Inhibitor -> Protein Kinase Inhibitor -> Tyrosine Kinase Inhibitor -> MET Tyrosine Kinase Inhibitor PF-02341066

MET Tyrosine Kinase Inhibitor PF-02341066 Definition

An orally bioavailable agent belonging to the class of c-met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors with potential antineoplastic activity. MET tyrosine kinase inhibitor PF-02341066 inhibits the membrane receptor MET and activation of the MET signaling pathway, which may block tumor cell growth, migration and invasion, and tumor angiogenesis in susceptible tumor cell populations.

MET Tyrosine Kinase Inhibitor PF-02341066 Synonyms

MET Tyrosine Kinase Inhibitor PF-02341066, PF-02341066

Terms in MET Tyrosine Kinase Inhibitor PF-02341066 category



Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods

No reproduction or republication permitted.